Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/1999

01-02-1999

Novel Carboxamide Derivative (IS-741) Attenuates Lung Injury in Rats with Cerulein-Induced Pancreatitis Complicated by Endotoxemia

Authors: Jian Liang, Yasuo Yamaguchi, Fujio Matsumura, Kazutoshi Okabe, Eiji Akizuki, Teishi Matsuda, Hajime Ohshiro, Shogo Nakano, Kojiroh Ishihara, Michio Ogawa

Published in: Digestive Diseases and Sciences | Issue 2/1999

Login to get access
Metadata
Title
Novel Carboxamide Derivative (IS-741) Attenuates Lung Injury in Rats with Cerulein-Induced Pancreatitis Complicated by Endotoxemia
Authors
Jian Liang
Yasuo Yamaguchi
Fujio Matsumura
Kazutoshi Okabe
Eiji Akizuki
Teishi Matsuda
Hajime Ohshiro
Shogo Nakano
Kojiroh Ishihara
Michio Ogawa
Publication date
01-02-1999
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 2/1999
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1026610702676

Other articles of this Issue 2/1999

Digestive Diseases and Sciences 2/1999 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine